KIF4モーターは,PARP-1の酵素活性を抑制することによって,活動に依存するニューロン生存を調節する
Ryosuke Midorikawa1, Yosuke Takei, Nobutaka Hirokawa
1Department of Cell Biology and Anatomy, Graduate School of Medicine, University of Tokyo, Hongo 7-3-1, Tokyo 113-0033, Japan.
Cell
|April 25, 2006
まとめ
キネシン超家族タンパク質4 (KIF4) は,脳の発達中にニューロン死亡を防ぐ. ポリ (ADP-リボース) ポリメラーゼ-1 (PARP-1) の活性を調節し,ニューロンの生存とホメオスタシスに不可欠です.
科学分野:
- 神経科学は神経科学である.
- 細胞生物学 細胞生物学
- 分子生物学は分子生物学である.
背景:
- アポトーシスは,脳の発達中のニューロン数を調節するために不可欠です.
- ポリ (ADP-リボース) ポリメラーゼ-1 (PARP-1) は,DNA修復と細胞ホメオスタシスに関与する核酵素である.
- キネシン超家族タンパク質4 (KIF4) は,微小管ベースのモータータンパク質です.
研究 の 目的:
- 若年神経細胞におけるアポトーシスの活動依存的予防におけるKIF4の役割を調査する.
- 脳発達中のPARP-1活性に対するKIF4の調節メカニズムを解明する.
主な方法:
- KIF4とPARP-1の相互作用を調査しました.
- KIF4-PARP-1解離に対するニューロン刺激 (膜脱極化とCaMKIIシグナル伝達) の効果を調べた.
- PARP-1からの解離後にKIF4の細胞下部位を追跡した.
主要な成果:
- KIF4のC端末ドメインは,PARP-1の活動を抑制する.
- 神経刺激により,KIF4がPARP-1からCaMKII媒介で解離され,PARP-1の活性が向上し,ニューロンの生存を促進します.
- 分離されたKIF4は,核から細胞質に転位し,微小管に依存した方法でニューライトの先端に移動します.
結論:
- KIF4は,PARP-1活性を調節することによって,転移後のニューロンの活動依存生存を調節する.
- このメカニズムは,神経細胞数を制御することによって,脳の発達に重要な役割を果たします.
関連する概念動画
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Restarting Stalled Replication Forks
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...


